LABHealthcareSmall-Cap

STANDARD BIOTOOLS INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for STANDARD BIOTOOLS INC. (LAB), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are LAB insiders buying or selling?

STANDARD BIOTOOLS INC. insiders reported 92 open-market buys ($69.3M) and 20 sells ($20.0M) across 112 Form 4 filings — a net buying position of $49.3M.

Source: SEC EDGAR Form 4

Key Statistics (as of Dec 5, 2025)

Total Form 4 filings
112
SEC EDGAR
Insider filers
12
Insider buys (92)
$69.3M
Insider sells (20)
$20.0M

Insider sentiment

Net buying

Net insider flow of $49.3M in net buying.

Recent LAB insider transactions

DateInsiderRoleTypeSharesPriceValue
Dec 5, 2025Casdin Partners Master Fund, L.P.Director, 10% OwnerPurchase350.0K$1.44$502.6K
Nov 26, 2025Eli CasdinDirector, 10% OwnerPurchase7.7M$1.31$10.1M
Nov 21, 2025Casdin Partners Master Fund, L.P.Director, 10% OwnerPurchase1.1M$1.28$1.4M
Nov 17, 2025Casdin Partners Master Fund, L.P.Director, 10% OwnerPurchase925.0K$1.22$1.1M
Nov 13, 2025Eli CasdinDirector, 10% OwnerPurchase1.2M$1.17$1.4M
Sep 12, 2025Casdin Partners Master Fund, L.P.Director, 10% OwnerPurchase100.0K$1.29$128.9K
Sep 5, 2025Casdin Partners Master Fund, L.P.Director, 10% OwnerPurchase500.0K$1.27$635.8K
Aug 27, 2025Casdin Partners Master Fund, L.P.Director, 10% OwnerPurchase525.0K$1.25$658.8K
Aug 16, 2025Eli CasdinDirector, 10% OwnerPurchase358.2K$1.24$443.0K
May 28, 2025Hanjoon Alex KimChief Financial OfficerSale1.4K$0.94$1.3K
May 28, 2025Sean MackaySVP & Chief Business OfficerSale13.2K$0.94$12.4K
May 28, 2025Michael EgholmPresident & CEOSale5.5K$0.94$5.2K
May 28, 2025Hanjoon Alex KimChief Financial OfficerSale1.4K$1.00$1.4K
May 28, 2025Michael EgholmPresident & CEOSale5.1K$1.00$5.1K
May 23, 2025Sean MackaySVP & Chief Business OfficerSale25.4K$1.02$25.8K
May 23, 2025Michael EgholmPresident & CEOSale4.7K$1.03$4.9K
May 23, 2025Hanjoon Alex KimChief Financial OfficerSale1.4K$1.03$1.4K
Mar 5, 2025Eli CasdinDirector, 10% OwnerPurchase4.8M$1.07$5.1M
Aug 30, 2024Eli CasdinDirector, 10% OwnerPurchase250.0K$2.19$546.8K
Aug 27, 2024Eli CasdinDirector, 10% OwnerPurchase750.0K$2.06$1.5M
Aug 22, 2024Eli CasdinDirector, 10% OwnerPurchase1.3M$1.88$2.4M
Aug 16, 2024Casdin Partners Master Fund, L.P.Director, 10% OwnerPurchase1.2M$1.59$1.9M
Aug 14, 2024Eli CasdinDirector, 10% OwnerPurchase1.6M$1.62$2.6M
Aug 10, 2024Eli CasdinDirector, 10% OwnerPurchase1.1M$1.61$1.7M
Aug 7, 2024Eli CasdinDirector, 10% OwnerPurchase1.2M$1.62$1.9M

Showing the 25 most recent of 112 Form 4 filings for STANDARD BIOTOOLS INC..

Most active LAB insiders

  • LEVIN CAPITAL STRATEGIES, L.P.53 filings
  • Casdin Partners Master Fund, L.P.22 filings
  • Levin Easterly Partners LLC10 filings
  • Caligan Partners LP8 filings
  • Samuel D Colella4 filings

Ask anything about LAB insider activity

Use Trabud's AI agent to query STANDARD BIOTOOLS INC.'s Form 4 history in plain English — "Show me LAB CEO purchases this year" or compare it against any other ticker.

Open the AI agent

LAB insider trading FAQ

Are STANDARD BIOTOOLS INC. insiders buying or selling?

Across 112 SEC Form 4 filings, STANDARD BIOTOOLS INC. (LAB) insiders reported 92 open-market purchases totaling $69.3M and 20 sales totaling $20.0M. That is a net buying position of $49.3M.

How many insiders trade LAB stock?

12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for STANDARD BIOTOOLS INC.. The most recent filing was accepted on Dec 5, 2025.

Where does Trabud get LAB insider trading data?

All LAB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content